LifeVantage Corporation Declares Quarterly Dividend
LifeVantage Corporation (NASDAQ: LFVN), a prominent health and wellness company specializing in cellular health products, has recently made headlines with the announcement of a new quarterly cash dividend. According to the company, the Board of Directors has approved a dividend of $0.045 per share. This payment is set to be disbursed on December 15, 2025, to all stockholders of record as of the close of business on December 1, 2025.
About LifeVantage Corporation
Founded in 2003 and based in Lehi, Utah, LifeVantage Corporation is known for its innovative approach to health and wellness through nutrigenomics, the study of how nutrition impacts gene expression. Their product range includes the acclaimed Protandim® line, designed to combat oxidative stress at the cellular level, and a variety of supplements and personal care products aimed at activating health benefits. Customers can also explore the TrueScience® product line, which encompasses skin and hair care solutions.
Products and Innovations
The company offers a diverse portfolio of health products, ranging from their flagship Protandim® offerings to the TrueScience® Liquid Collagen and the MindBody GLP-1 System™, which have garnered attention for their focus on holistic health. Additionally, LifeVantage provides activation-supporting nutrients like Omega and D3+, as well as the AXIO® nootropic energy drink mixes that help boost both mental clarity and overall well-being.
Strengthening Financials
The recent approval of the cash dividend indicates LifeVantage's commitment to returning value to its shareholders while maintaining a strong financial foundation. By continually innovating and expanding its product line, the company reinforces its position in the health industry, which is vital as more individuals seek natural solutions to enhance their health.
Market Performance
As of the latest reports, LifeVantage's stock performance reflects ongoing interest from investors. Although currently trading at approximately $6.91, the company remains dedicated to its long-term growth strategy. The downward trend indicated by a decrease of 5.86% in recent trading sessions highlights the volatile nature of the market and the importance of strategic planning and execution.
Remaining Connected with Investors
LifeVantage acknowledges the importance of transparency and communication with its shareholders. By providing consistent updates through press releases and financial reports, the company ensures that investors remain informed about their investments. The organization values its shareholders and seeks to enhance their confidence through effective engagement.
Investor Relations
For further inquiries or detailed information, investors and interested parties can reach out to Reed Anderson at ICR, who serves as the main contact for investor relations. He can be reached at (646) 277-1260 or via email for personalized assistance regarding financial matters or company updates.
Frequently Asked Questions
What is the amount of the dividend announced by LifeVantage?
LifeVantage announced a quarterly cash dividend of $0.045 per share to be paid on December 15, 2025.
When will the dividend be paid out to shareholders?
The dividend will be paid on December 15, 2025, to all stockholders of record as of December 1, 2025.
What products does LifeVantage specialize in?
LifeVantage specializes in health and wellness products, particularly in nutrigenomics, including supplements like Protandim® and the TrueScience® product line.
Where is LifeVantage headquartered?
LifeVantage Corporation is headquartered in Lehi, Utah.
How can investors contact LifeVantage for more information?
Investors can contact Reed Anderson at ICR at (646) 277-1260 for inquiries related to investor relations.
